| Net Cash Provided by (Used in) Operating Activities |
$-91,517 |
USD |
12% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$50,000 |
USD |
-72.22% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
75,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
21,323,312 |
shares |
4.4% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$58,953 |
USD |
-61.07% |
Q3 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$287,000 |
USD |
70% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$298,000 |
USD |
76% |
Q2 2025 |
FY 2025 |
| Operating Lease, Liability |
$0 |
USD |
-100% |
Q2 2025 |
FY 2025 |
| Operating Lease, Liability, Current |
$1,609 |
USD |
-91.32% |
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Additional Paid in Capital |
$1,275,109 |
USD |
17% |
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q1 2026 |
| Interest Expense |
$12,047 |
USD |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |